Cargando…
CD47 prevents the elimination of diseased fibroblasts in scleroderma
Scleroderma is a devastating fibrotic autoimmune disease. Current treatments are partly effective in preventing disease progression but do not remove fibrotic tissue. Here, we evaluated whether scleroderma fibroblasts take advantage of the “don’t-eat-me-signal” CD47 and whether blocking CD47 enables...
Autores principales: | Lerbs, Tristan, Cui, Lu, King, Megan E., Chai, Tim, Muscat, Claire, Chung, Lorinda, Brown, Ryanne, Rieger, Kerri, Shibata, Tyler, Wernig, Gerlinde |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7455137/ https://www.ncbi.nlm.nih.gov/pubmed/32814713 http://dx.doi.org/10.1172/jci.insight.140458 |
Ejemplares similares
-
Expansion of Bone Precursors through Jun as a Novel Treatment for Osteoporosis-Associated Fractures
por: Lerbs, Tristan, et al.
Publicado: (2020) -
47XXY and 47XXX in Scleroderma and Myositis
por: Scofield, R. Hal, et al.
Publicado: (2022) -
Activation of JUN in fibroblasts promotes pro-fibrotic programme and modulates protective immunity
por: Cui, Lu, et al.
Publicado: (2020) -
Innate immune cell activation causes lung fibrosis in a humanized model of long COVID
por: Cui, Lu, et al.
Publicado: (2023) -
Abstract 186: CD36 Antagonism Minimizes Skin Scarring By Inhibiting JUN-dependent Fibrotic Pathways Within Fibrogenic Fibroblast Subpopulations
por: Borrelli, Mimi R., et al.
Publicado: (2020)